RECOMBINANT YEAST CELLS PRODUCING POLYLACTIC ACID AND THEIR USE Russian patent published in 2021 - IPC C12N15/54 C12N15/81 C12N9/10 C12N1/19 C12P7/56 C08G63/08 

Abstract RU 2758138 C2

FIELD: chemistry.

SUBSTANCE: group of inventions relates to a recombinant yeast cell suitable for the production of polylactic acid (hereinafter – PLA), and its use. A recombinant yeast cell suitable for the production of PLA is proposed, containing and expressing a gene encoding lactyl-CoA-synthase and a gene encoding polyhydroxyalkanoate synthase (hereinafter – PHA) (PhaCp), additionally containing a peroxisomal targeted sequence (PTS). Lactyl-CoA-synthase is selected from a group consisting of CoA transferase, propionyl-CoA transferase (Pctp) or CoA ligase. At least one activity of lactic acid oxidoreductase is inactivated in the cell, preferably a gene encoding lactic acid dehydrogenase is inactivated, more preferably a gene encoding D-lactic acid dehydrogenase is inactivated. A recombinant yeast cell is designed for the expression of lactyl-CoA-synthase in cytosol and for the expression of PHA synthase in peroxisome of the specified cell. A method for producing PLA using the specified cell, enzymatic broth for producing PLA containing the specified cell are also proposed.

EFFECT: group of inventions provides the production of high amounts of PLA.

13 cl, 10 dwg, 5 tbl, 4 ex

Similar patents RU2758138C2

Title Year Author Number
ANTIBODIES TO BTN3A AND THEIR USE IN THE TREATMENT OF CANCER OR INFECTIOUS DISEASES 2019
  • Truneh, Alemseged
  • Olive, Daniel
  • Pasero, Christine
  • De Gassart, Aude
RU2800726C2
VARIANTS OF ACID ALPHA-GLUCOSIDASE AND THEIR USE 2017
  • Mingozzi, Federico
  • Ronzitti, Giuseppe
RU2780410C2
IMMUNOCYTOKINES BASED ON IL-15 AND IL-15Rα OF THE SUSHI DOMAIN 2012
  • Morisso Sebastyan Danel
  • Teppa Zheraldin
  • Zhak Yannik Loran Zhozef
  • Rober Bruno Zhilber Mark
  • De Martinoff Gi Lyuk Mishel
  • Beshar David
RU2763298C2
BTN2-SPECIFIC ANTIBODIES AND USE THEREOF 2020
  • Foucher, Etienne
  • Cano, Carla
  • Le, Kieu Suong
  • Pasero, Christine
  • Olive, Daniel
RU2821703C2
CANCER-RELATED IMMUNOSUPPRESSION INHIBITOR 2018
  • Barret Jean-Marc
  • Prost Jean-Francois
  • Lahmar Mehdi
  • Degove Stephane
  • Bougherara Houcine
  • Donnadieu Emmanuel
RU2805232C2
TREATMENT OF ABNORMAL VISCERAL FAT DEPOSITION WITH FIBROBLAST GROWTH FACTOR 3 (sFGFR3) SOLUBLE POLYPEPTIDES 2018
  • Guz, Elvire
  • Garsiya, Stefani
RU2794170C2
POLYPEPTIDES THAT ARE SOLUBLE RECEPTORS OF FIBROBLAST GROWTH FACTOR 3 (sFGFR3), AND WAYS OF THEIR APPLICATION 2017
  • Guz, Elvire
  • Garsiya, Stefani
RU2751483C2
GENE THERAPY OF HYPOPHOSPHATEMIC DISEASES ASSOCIATED WITH FIBROBLAST GROWTH FACTOR 23 2020
  • Rontsitti, Dzhuzeppe
  • Zhoz, Luiza
  • Sharl, Severin
  • Mingotstsi, Frederiko
RU2815545C2
USE OF THE ANTI-O-ACETYLATED GANGLIOSIDE GD2 ANTIBODY FOR IMPROVING THE THERAPEUTIC POTENTIAL OF DRUGS 2017
  • Birkl, Stefan
  • Flerans, Zhyulen
  • Farazh, Sebastyan
  • Le Dussal, Zhan-Mark
  • Koshonno, Deni
  • Term, Mikael
  • Assulin, Brizhitt
RU2771173C2
ISOLATED HUMAN CD45RC ANTIBODY, NUCLEIC ACID, EXPRESSION VECTOR, CELL, PHARMACEUTICAL COMPOSITION, USE THEREOF, IN VITRO METHOD OF DETECTING hCD45RC 2019
  • Guilionneau, Carole
  • Anegon, Ignacio
RU2826421C2

RU 2 758 138 C2

Authors

Dusseaux, Simon

Lajus, Sophie

Borsenberger, Vinciane

Verbeke, Jonathan

Bordes, Florence

Marty, Alain

Nicaud, Jean-Marc

Beopoulos, Athanasios

Dates

2021-10-26Published

2016-12-15Filed